DEBAMESTROCEL EFFECT ON CLINICAL AND BIOMARKER ENDPOINTS BY UNC13A GENOTYPES IN PHASE 3 ALS TRIAL
2025 · Cytotherapy · 0 citations
https://doi.org/10.1016/j.jcyt.2025.03.007
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1.7K
Citations
13
h-index
13
i10-index
J.S. Katz is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Peripheral Neuropathies and Disorders & Amyotrophic Lateral Sclerosis Research & Hereditary Neurological Disorders. The author has an h-index of 13, co-authored 23 publications.
Click to start Chat